Over the last week, the United States market has seen a 4.4% increase, contributing to an impressive 32% rise over the past year, with earnings expected to grow by 16% annually. In such a thriving environment, identifying stocks that are potentially undervalued can offer investors opportunities for growth by focusing on companies with strong fundamentals and attractive valuations relative to their peers.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
WesBanco (WSBC)	$36.12	$70.54	48.8%
Power Solutions International (PSIX)	$85.40	$170.28	49.8%
Ferroglobe (GSM)	$4.35	$8.45	48.5%
FB Financial (FBK)	$54.70	$107.76	49.2%
Dynatrace (DT)	$33.27	$65.44	49.2%
DNOW (DNOW)	$11.96	$23.83	49.8%
Coastal Financial (CCB)	$82.04	$161.96	49.3%
BioLife Solutions (BLFS)	$20.27	$39.78	49%
Ategrity Specialty Insurance Company Holdings (ASIC)	$20.51	$40.96	49.9%
AppLovin (APP)	$433.51	$860.49	49.6%

Here's a peek at a few of the choices from the screener.

Power Solutions International (PSIX)

Overview: Power Solutions International, Inc. designs, engineers, manufactures, markets, and sells engines and power systems globally with a market cap of approximately $1.80 billion.

Operations: The company's revenue is primarily derived from its Engineered Integrated Electrical Power Generation Systems segment, which generated $722.41 million.

Estimated Discount To Fair Value: 49.8%

Power Solutions International appears undervalued based on discounted cash flow analysis, trading at US$85.40 compared to an estimated future cash flow value of US$170.28. Despite a volatile share price and recent legal issues, the company reported significant sales growth for 2025 with earnings per share improving from the previous year. However, concerns persist due to auditor doubts regarding its going concern status and challenges in the data center market impacting margins.

Caris Life Sciences (CAI)

Overview: Caris Life Sciences, Inc. is an artificial intelligence TechBio company offering molecular profiling services both in the United States and internationally, with a market cap of approximately $5.41 billion.

Operations: The company generates revenue primarily through its biotechnology segment, which accounts for $812.03 million.

Estimated Discount To Fair Value: 48.2%

Caris Life Sciences is trading at US$20.19, significantly below its estimated future cash flow value of US$38.99, suggesting potential undervaluation based on discounted cash flow analysis. Recent innovations in AI-driven molecular insights and a robust financing agreement enhance its strategic position in precision oncology. Although the company reported strong revenue growth and improved earnings last year, forecasts indicate slower revenue growth compared to historical performance, with profitability expected within three years.

Toast (TOST)

Overview: Toast, Inc. operates a cloud-based digital technology platform for the restaurant industry globally and has a market cap of approximately $15.99 billion.

Operations: The company's revenue primarily comes from its data processing segment, which generated $6.15 billion.

Estimated Discount To Fair Value: 19.1%

Toast is trading at US$27.10, below its estimated future cash flow value of US$33.52, indicating potential undervaluation based on cash flows. The company recently launched Toast Drive-Thru to enhance quick-service restaurant efficiency and partnered with Ike’s Love & Sandwiches to expand its technology suite across 100 locations. Despite slower expected revenue growth compared to historical performance, Toast's earnings are forecasted to grow significantly faster than the broader U.S. market over the next three years.

Summing It All Up

• Click through to start exploring the rest of the 149 Undervalued US Stocks Based On Cash Flows now.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.